BLUEBIRD BIO INC

BLUE NASDAQ

tencennts

Weekly Chart. RSI divergence. Looks for that reversal to test its first resistance.

HorizontalPriceLevelsTrading

Bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees,...

CobraTrader13

- PDUFA meeting this weekend - Looking for wave 5 - Undervalued - Bottom of RSI - Important buy zone Target $35 Stop Loss $26

Cidoguy

Mega pump it!

Antikythera_Mechanism

Fundamental Analysis: Blue Bird has suffered tremendous defeat in the stock market. Recently, a lawsuit was filed against Blue Bird, as backlash for failing to inform investors of changes with their expected timeline for completion of data release and FDA decisions. However, this coming March 27th Blue Bird is scheduled for a priority review of their joint...

decaro

Love it or hate it, it's BLUE. Anecdotal, non-scientific evidence of a serious side effect prompted a halt of a trial of a product, and the company is investigating. No one knows anything else until the company reports. End. Of. Story. There is a strong bid today, and here you can see why. BLUE has clipped long-term support and bounced nicely off of it for it's...

PeterSl

Price sold off on bad news and awaits confirmation of the claims and seems to be consolidating. Should the claims be confirmed, it is bad news for the Company. Should the news be disputed, the price is likely to reverse into the consolidation area of the previous triangle. Keep a tight stop below the consolidation area.

sfhenderson17

But I'm still thinking that there's something here...

sfhenderson17

I'm usually a little early, so staying patient for now

sfhenderson17

Going to start my research on this...

mes_que_un_club

Beautiful backtest to iceline from 2016 - long term play here.

DCuenca

Stock presents a bullish technical scenario. REASONS -breaking the bearish downtrend maintained since March 2018. -Bullish divergence -Inverted Head & Shoulders on smaller TF We could see the price heading to close the GAP in the 58's region.

ChimpCapital007

PT $60 +

TradingNomadic

#BLUE is a candidate I've been watching for weeks. Bluebird bio is bio tech company that develops therapeutics for genetic diseases and cancer treatment. I posted this one originally on the 19th. My personal target will be 113.47 but we could ultimately see $137-163 beyond that in time. First target id expect to see is 72.37 if it ends up playing out. The...

DF1

BLUEBIRD BIO: -Declining sell volume -Wavetrend indicator suggesting upside -Struggling with the 21EMA on the weekly Timeframe ENTRY: Aggressive -Laddering in your orders within the current area Conservative: -Wait for a weekly close above the 21EMA

Vibranium_Capital

good dip entry here, but we could see a little bit more downside until we find the bottom, in my opinion the bottom will be around 30-35 then we can see a test of the downtrend line after that, and obviously even higher if it breaks. leap calls if thats an option. be paytient ;) leave a like/follow if you enjoy ideas <3

SewellBrokerage

wow this thing has every bullish indicator. such a wonderful set up.

ChimpCapital007

Struggle// PT $60